Please login to the form below

Not currently logged in
Email:
Password:

EMA’s Paediatric Committee elects new leaders

Dirk Mentzer and Henk van den Berg elected as chair and vice-chair

Dirk Mentzer The European Medicines Agency's (EMA) Paediatric Committee (PDCO) last week elected Dirk Mentzer and Henk van den Berg chair and vice-chair, respectively, at its September meeting. Both have been elected for a three-year term. 

A paediatrician by training, Dr Mentzer is currently head of the pharmacovigilance unit at the Paul-Ehrlich Institut in Frankfurt, Germany.  He is an expert in paediatric specialist training, including neonatology and paediatric accident and emergency admissions. 

Dr Van den Berg is a consultant in paediatric haematology / oncology at the Medicines Evaluation Board in Utrecht, the Netherlands.  His areas of expertise include paediatric haematology, clinical pharmacology and medical education. 

On their election, Mentzer and van den Berg thanked outgoing chair Daniel Brasseur, who has left the PDCO to become a member of the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP).

Both Mentzer and van den Berg have been members of the PDCO since it was established in 2007. The committee's main role is to assess the content of paediatric investigation plans (PIPS). It meets for three days each month at the EMA in London.

19th September 2013

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

Measures for measures
Why pharma’s marketing metrics must close the loop...
Where next in Alzheimer’s disease R&D?
How past failures and emerging biology are reshaping drug development...
Brain scan
Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...

Infographics